Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
A phase 2 trial of Patient-derived organoids in Colorectal cancer, run by Oslo University Hospital, now recruiting.
Overview
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer is a phase 2 interventional study registered as NCT05725200 by Oslo University Hospital, with 40 participants planned, started 2022-09-27 and due to reach its primary completion in 2038-12-31. Interventions recorded: Alectinib, Cetuximab, Crizotinib, Dasatinib, Everolimus, Encorafenib, Gemcitabine, Idelalisib, Larotrectinib, Methotrexate, Palbociclib, Panobinostat, Pembrolizumab, Petrozumab, Trastuzumab, Talazoparib, Venetoclax. Conditions recorded: Metastatic Colorectal Cancer.
Linked to the technology Patient-derived organoids because the registry's title names it ("patient derived organoids") and Colorectal cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialPanobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma
Shares Panobinostat, Gemcitabine and the tag pipeline.
- TrialStudy of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)
Shares Cetuximab, Pembrolizumab, Colorectal cancer and the tag pipeline.
- TrialA Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Shares Idelalisib, Venetoclax and the tag pipeline.
- TrialPhase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma
Shares Panobinostat and the tag pipeline.
- TrialEfficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)
Shares Panobinostat and the tag pipeline.
- TrialStudy for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies
Shares Palbociclib, Cetuximab and the tag pipeline.
- TrialA Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC
Shares Everolimus, Palbociclib and the tag pipeline.
- TrialPrecise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids
Shares Patient-derived organoids, Gemcitabine and the tag pipeline.